PaxVax CVD 103-HgR single-dose live oral cholera vaccine

PaxVax CVD 103-HgR single-dose live oral cholera vaccine

Introduction: Cholera remains a problem in developing countries and a risk for travelers. Hypochlorhydria, blood group O, cardiac and renal disease increase the risk of developing cholera gravis. Oral vaccines containing inactivated Vibrio cholerae and requiring two doses are available in some count...

Full description

Bibliographic Details
Main Authors: Myron M. Levine, Wilbur H. Chen, James B. Kaper, Michael Lock, Lisa Danzig, Marc Gurwith
Format: Article
Language:English
Published: Taylor & Francis Group 2017-03-01
Series:Expert Review of Vaccines
Subjects:
cholera
cholera vaccines
live oral vaccine
travelers’ vaccines
vaccine
Online Access:http://dx.doi.org/10.1080/14760584.2017.1291348

Internet

http://dx.doi.org/10.1080/14760584.2017.1291348

Similar Items